News
3hon MSN
FDA considering pulling authorization of Pfizer’s COVID-19 vaccine for healthy children under 5
The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
11hon MSN
Got the sniffles? Here’s what to know about summer colds and the COVID-19 variant called stratus
COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S.
The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy ...
“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.
The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S.
Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 ...
Europe, Ukraine hope for chilly Putin summit ▪ The Hill interview: Newsom defends redistricting fight ▪ Progressives take center stage in mayoral contests ▪ Israel steps up ...
Dividend stocks are a time-tested way to retire or protect your portfolio if you are already retired. Their yield can give ...
Traws Pharma, Inc. ( NASDAQ: TRAW) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Charles Parker - Interim Chief Financial Officer David Pauza - Corporate Participant Iain D. Dukes - ...
Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 (ratutrelvir) and influenza (Tivoxavir marboxil, TXM) Prioritization of ratu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results